Ampullary adenocarcinoma is a rare cancer that arises in the ampulla of Vater, where the bile and pancreatic ducts meet the small intestine. It's classified into two main types-intestinal and pancreaticobiliary-and is recorded under ICD-10 code C24.1. Early detection can significantly improve outcomes.
Symptoms often overlap with other digestive conditions, but may include:
The exact cause is often unclear, but several risk factors have been identified:
We specialize in the diagnosis and treatment of rare digestive cancers like ampullary adenocarcinoma, delivering compassionate, patient-centered care. Our Houston-based team of gastroenterologists, oncologists, surgeons and dietitians works together to craft personalized treatment plans-whether it's minimally invasive endoscopic ampullectomy, Whipple surgery, or tailored chemotherapy and nutrition support.
Ready to take the next step? Early evaluation is key to better outcomes. Call us now or book an appointment online today and get the expert care you deserve.
We've successfully treated more than 1K patients, helping individuals improve their digestive health and overall well-being through expert, personalized care.
With over 20 years of experience, GastroDoxs has been a trusted provider of gastroenterology care, focusing on delivering the best outcomes for patients
The ICD-10 code for ampullary adenocarcinoma is C24.1, used for accurate medical documentation and billing.
Diagnosis typically involves blood tests, cross-sectional imaging (CT or MRI), and an endoscopic biopsy to examine tissue from the ampulla of Vater.
Yes. When detected early, the intestinal type can often be completely removed by surgery, leading to a potential cure.
"Intestinal type" refers to tumor cells that under the microscope resemble the lining of the small intestine, which can influence treatment decisions and prognosis.
Yes. At GastroDoxs in Houston, our team includes gastroenterologists, surgeons, oncologists, and dietitians experienced in treating ampullary adenocarcinoma.
No. It's very rare, accounting for less than 1% of all digestive tract cancers.
Surgical risks may include infection, bleeding, or delayed gastric emptying. These complications are uncommon when performed by experienced surgeons.
Not always. The need for chemotherapy depends on the cancer stage and pathology findings. Your care team will recommend the best approach for you.
Seek medical evaluation right away if you experience jaundice (yellowing of skin or eyes), abdominal pain, or changes in stool or urine color.
Yes. We offer personalized nutrition plans and ongoing dietitian support before, during, and after treatment to help you stay strong and manage side effects.